http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844590-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
filingDate | 2015-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104844590-B |
titleOfInvention | A kind of N methyl Ciprofloxacin (rhodanine beta-unsaturated ketone) amide derivatives and its preparation method and application |
abstract | The invention discloses a kind of N methyl Ciprofloxacin (rhodanine beta-unsaturated ketone) amide derivatives and its preparation method and application, using such as following formula I chemical structure of general formula: A kind of N methyl Ciprofloxacin (rhodanine beta-unsaturated ketone) amide derivatives of the present invention, realize the third fluoquinolone of ring skeleton, acid amides and rhodanine α , β The superposition of three kinds of pharmacophores of beta-unsaturated ketone, so as to add the antitumor activity of compound, reduction to the toxic side effect of normal cell, can be used as anti-tumor active substance developing anti-tumor medicaments. |
priorityDate | 2015-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.